FDA approves Zavesca

By BC Staff | Aug 1, 2003 | 7:00 AM GMT

The FDA granted marketing approval for Zavesca miglustat capsules from Celltech (LSE:CCH; CLL) and Actelion (SWX:ATLN). Zavesca is indicated

Read the full 192 word article

How to gain access

Continue reading with a
two-week free trial.